SS-008871

N/A

Report date: 2023/03/21 17:49:43
NME

Base Information

Drug NameSS-008871
Drug Alias NameSS-008871
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA polymerase theta inhibitors
TargetsDNA polymerase theta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A